Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, November 9, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
Life Sciences Times
-
November 7, 2025
Pharma
Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart
Life Sciences Times
-
November 6, 2025
Pharma
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
October 31, 2025
Pharma
Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration
Life Sciences Times
-
October 28, 2025
Pharma
Corsera Health Files First Phase 1 Clinical Trial Application for Preventive RNAi Medicine Targeting Cardiovascular Disease
Life Sciences Times
-
October 27, 2025
Pharma
Prilenia Announces Completion of Patient Enrollment Ahead of Schedule in the Pridopidine Arm of the HEALEY ALS Platform Trial
Life Sciences Times
-
January 5, 2022
0
Pharma
NiKang Therapeutics and AVEO Oncology Announce a Clinical Trial Collaboration and Supply Agreement to Evaluate the Combination of NKT2152, a HIF2α Inhibitor, and FOTIVDA
Life Sciences Times
-
January 5, 2022
0
Pharma
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Life Sciences Times
-
January 5, 2022
0
Pharma
Alentis Therapeutics Starts First-in-Human Clinical Trial for the Treatment of Liver and Kidney Fibrosis
Life Sciences Times
-
January 4, 2022
0
Pharma
ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder
Life Sciences Times
-
January 4, 2022
0
Pharma
PharmaJet partner Zydus Cadila Announces COVID-19 Vaccine Expansion Plan to Multiple Countries With Korean Firm
Life Sciences Times
-
January 4, 2022
0
Pharma
LEO Pharma Announces FDA Approval of Adbry™ (tralokinumab) as the First and Only Treatment Specifically Targeting IL-13 for Adults With Moderate-to-Severe Atopic Dermatitis
Life Sciences Times
-
December 28, 2021
0
Pharma
Theramex Announces an Agreement with Enzene Biosciences Limited for the Development and Commercialisation of Tocilizumab
Life Sciences Times
-
December 23, 2021
0
Pharma
Gilead Announces New England Journal of Medicine Publication of Data Demonstrating Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in High-Risk Patients With COVID-19
Life Sciences Times
-
December 23, 2021
0
Pharma
EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities
Life Sciences Times
-
December 23, 2021
0
Pharma
Aarvik Therapeutics and ArriVent Biopharma Announce Research Collaboration to Advance Novel Oncology Drug Candidate Using Aarvik’s Proprietary Modular Antibody Platform
Life Sciences Times
-
December 23, 2021
0
Pharma
Alnylam Submits CTA Application for ALN-APP, an Investigational RNAi Therapeutic for the Treatment of Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Life Sciences Times
-
December 22, 2021
0
1
...
55
56
57
...
83
Page 56 of 83
Most Read
Arena BioWorks to Shut Down Amid Challenging Biotech Market Conditions
November 7, 2025
A2 Biotherapeutics Presents Initial EVEREST-2 Data, Including First Complete Response to CAR T-Cell Therapy in a Patient with NSCLC
November 7, 2025
Dechra Becomes Human-Animal Bond Certified Company to Support Veterinarians and Public Health
November 7, 2025
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
November 7, 2025